Dr. Songnian Lin is an Executive Scientific Director/Distinguished Scientist of Discovery Chemistry, Merck Research Laboratories, located in Kenilworth, New Jersey, USA. Dr. Lin has a broad research interest including diabetes and obesity, hypertension, anemia, arthritis, and cancer, and has successfully brought multiple drug candidates to various stages of clinical testing. Dr. Lin currently oversees multiple drug discovery programs in diabetes, cancer, and anti-inflammation/fibrosis areas, with diverse chemical modalities ranging from small molecules, hormone peptides, macrocyclic peptides, and conjugates; Prior to Merck, Dr. Lin obtained his PhD from Stony Brook University (advisor: Iwao Ojima) and performed post-doctoral research at the Memorial Sloan-Kettering Cancer Center, New York, as an US Army Breast Cancer Research Fellow (advisor: Samuel Danishefsky).
Compétences
medicinal chemistry, organic chemistry
drug discovery, small molecule, peptide, protein conjugates
Laissez votre note